Topic List : Genetics
Undiagnosed patients get answers
A network of doctors that aims to diagnose mystery diseases has named 31 newly identified conditions and diagnosed more than 100 previously unsolved cases, according to a new study.
Mutations point to possible drug targets
Genetic data from nearly 300,000 patients has helped scientists find new potential drug targets for heart disease and diabetes, while shedding more light on the genetics of cholesterol, according to a new study.
Human ‘exposome’ revealed
Stanford scientists have measured the human “exposome,” or the particulates, chemicals and microbes that individually swaddle us all, in unprecedented detail.
‘Cascade’ testing identifies relatives at risk
An online effort coupled with lower costs significantly increased the proportion of cancer patients’ relatives who chose to undergo genetic testing for cancer-associated mutations in Stanford study.
Same mutations fuel cancer metastases
The true driver mutations of cancer are almost always common to all metastases in an individual, according to a Stanford scientist and other researchers.
Predicting aneurysm risk from DNA
By combining genome-sequence information and health records, Stanford scientists have developed a new algorithm that can predict the risk of abdominal aortic aneurysm, and potentially could be used for any number of diseases.
Safer gene therapy?
A new study gives Stanford researchers hope that they may have solved a big problem plaguing gene therapy: the prospect of an autoimmune attack.
Computers help diagnose rare diseases
A Stanford method for comparing patients’ symptoms and gene data to the medical literature could greatly speed the diagnosis of rare genetic diseases.
Repeated DNA arrays can confer psychiatric risks
Repeated, human-specific DNA sequences are tied to an increased risk of psychiatric disorders, a Stanford study finds. It might be possible to treat the diseases with existing drugs.
Genetic screen predicts osteoporosis risk
A new genetic screen may be able to predict low bone-mineral density, osteoporosis and fracture risk prior to clinical symptoms, according to a retrospective study of nearly 400,000 people by a Stanford researcher.